Pfizer is selling its remaining stake in partner BioNTech, which developed the Comirnaty COVID-19 vaccine. This comes as Pfizer’s stock fell 5% before the market opened on Thursday. The decision may impact the US pharma giant’s ability to benefit from BioNTech’s future vaccine sales.
Source: https://seekingalpha.com/news/4521405-pfizer-divest-remaining-stake-biontech